Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and 5-Fluorouracil in Metastatic Breast Cancer
NCT00015886Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 1997
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Wake Forest University Health Sciences. Started Jan 1997; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00015886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015886.